title: Current treatment options in vestibular migraine.
abstract: Approximately 1% of the general population in western industrialized countries suffers from vestibular migraine. However, it remains widely unknown and often under diagnosed despite the recently published diagnostic criteria for vestibular migraine. Treatment trials that specialize on vestibular migraine are scarce and systematic randomized controlled clinical trials are now only emerging. This review summarizes the knowledge on the currently available treatment options that were tested specifically for vestibular migraine and gives an evidence-based, informed treatment recommendation with all its limitations. To date only two randomized controlled treatment trials provide limited evidence for the use of rizatriptan and zolmitriptan for the treatment of vestibular migraine attacks because of methodological shortcomings. There is an ongoing multicenter randomized placebo-controlled trial testing metoprolol 95 mg vs. placebo (PROVEMIG-trial). Therefore, the therapeutic recommendations for the prophylactic treatment of vestibular migraine are currently widely based on the guidelines of migraine with and without aura as well as expert opinion.
authors.affiliation: Department of Neurology, Vertigo and Dizziness Center, University of Duisburg-Essen , Essen , Germany.
authors.forename: Mark
authors.initials: M
authors.lastname: Obermann
authors.affiliation: Department of Neurology, German Center for Vertigo and Balance Disorder, Ludwig-Maximillians-University Munich , Munich , Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Strupp
keywords: dizziness; gait disturbance; migraine; migraine with aura; vertigo; vestibular migraine